Harbour Investments’s Natus Medical Inc NTUS Stock Holding History

Harbour Investments’s Portfolio NTUS Stock Details NTUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-425	Closed	-$11K	–	3980
2021 Q3	$11K	Buy	+425	New	+$10.8K	﹤0.01%	2638

Other funds holding NTUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Harbour Investments's NTUS Position: Q4 2021 in Review

Harbour Investments sold out of Natus Medical Inc (NTUS) in Q4 2021, closing a stake of 425 shares — an estimated $11K sold.

Harbour Investments first reported a position in NTUS in Q3 2021 and held it in 1 quarter. The position peaked at $11K in Q3 2021. 172 funds tracked by Wall St. Rank hold NTUS as of Q4 2021.

Harbour Investments reported no remaining Natus Medical Inc position as of Q4 2021 after selling out during the quarter.
Harbour Investments sold 425 Natus Medical Inc shares in Q4 2021, an estimated $11K.
Harbour Investments first reported a position in Natus Medical Inc in Q3 2021 and held it in 1 quarter.
Harbour Investments's Natus Medical Inc position peaked at $11K in Q3 2021.
172 funds tracked by Wall St. Rank held Natus Medical Inc as of Q4 2021.

Based on Harbour Investments's 13F filing for Q4 2021, filed 16 Feb 2022.